Merck sued the U.S. government on Tuesday (June 6), ... Merck sues US government to halt drug price negotiation law 01:25 Apple stock slips despite strong iPhone sales 01:05 Bankman-Fried ...
(Reuters) - The U.S. health regulator's advisers said on Friday that data on Merck's chronic cough drug gefapixant does not provide sufficient evidence to prove its clinical benefit for patients.
Shock ruling from Republican-appointed appeals court prevents outside groups or citizens seeking to enforce voting rights law A federal appeals court shocked voting rights groups on Monday with a ...
Nov 15 (Reuters) - The U.S. Food and Drug Administration's reviewers on Wednesday flagged concerns that data on Merck's MRK.N chronic cough drug might not be sufficient enough to prove the ...
Three years after the major cyber-incident at SolarWinds, the US Securities and Exchange Commission (SEC) is suing the firm. In the lawsuit, the government agency alleges that the company and ...
Huawei has filed a lawsuit against the US government over a ban that restricts federal agencies from using its products. It said the US failed to provide evidence to support the ban, and the firm ...
To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...
WASHINGTON — Chinese telecoms giant Huawei sued the U.S. government Wednesday night, asserting that Congress violated the constitution last year when it barred federal agencies from using the ...
An Arkansas man of Palestinian descent is suing the U.S. government in an effort to have his wife and their two young children, both American citizens, evacuated from Gaza amid Israel’s war against ...
University of Michigan graduate Joseph Hardig III, 65, of suburban Detroit, is suing the state after losing his claim to his "G0BLUE" vanity license plate number. Hardig's lawsuit seeks to prevent ...
(Reuters) -The U.S. health regulator's staff on Wednesday flagged concerns that data on Merck's chronic cough drug might not be enough to prove the treatment's meaningful benefit, documents ...
